| Credicorp Ltd.: Credicorp Announces Director Nominees for the 2026 Annual General Meeting of Shareholders |
Globe Newswire |
02/27 |
07:30 |
| TransAlta Enters Memorandum of Understanding for Data Centre Development at Keephills Site with Potential to Scale Up to 1 GW |
Globe Newswire |
02/27 |
07:06 |
| TransAlta to Host Investor Day |
Globe Newswire |
02/27 |
07:06 |
| TransAlta Reports Fourth Quarter and Year End 2025 Results, Announces Data Centre Agreement, Declares Dividend Increase and Provides 2026 Outlook |
Globe Newswire |
02/27 |
07:05 |
| Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results |
Globe Newswire |
02/27 |
07:05 |
| Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment |
Globe Newswire |
02/27 |
07:03 |
| Gogo Announces Fourth Quarter and Full Year 2025 Results |
Globe Newswire |
02/27 |
07:00 |
| Aurora Mobile Partners with China Post Securities to Deliver Millisecond Messaging and Enhance Digital Financial Services |
Globe Newswire |
02/27 |
07:00 |
| Enwex Netherlands, France and Spain Wind Futures Now Live for Trading on Abaxx Exchange |
Globe Newswire |
02/27 |
07:00 |
| ADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE |
Globe Newswire |
02/27 |
07:00 |
| Boralex and Six Nations of the Grand River Development Corporation Commission Canada’s Largest Operating Battery Storage Facility |
Globe Newswire |
02/27 |
07:00 |
| Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment |
Globe Newswire |
02/27 |
07:00 |
| ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Financial Guidance |
Globe Newswire |
02/27 |
06:50 |
| SourceDay Named to The Hackett Group’s 2025–2026 50 to Know List |
Globe Newswire |
02/27 |
06:41 |
| SMR Investor Alert: NuScale Power Corporation Securities Fraud Class Action Focuses on ENTRA1 Issues; BFA Law Notifies Investors of April 20 Court Deadline |
Globe Newswire |
02/27 |
06:36 |
| Stacey Caywood has officially assumed the role of CEO at Wolters Kluwer |
Globe Newswire |
02/27 |
06:30 |
| BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance |
Globe Newswire |
02/27 |
06:00 |
| Amneal Reports Fourth Quarter and Full Year 2025 Financial Results |
Globe Newswire |
02/27 |
06:00 |
| Johnson Outdoors Announces Cash Dividend |
Globe Newswire |
02/27 |
06:00 |
| Press Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness |
Globe Newswire |
02/27 |
05:55 |
| 2026 Hunnan Science and Technology City Conference on Advancing the Deep Integration of Scientific and Technological Innovation with Industrial Innovation Successfully Held |
Globe Newswire |
02/27 |
04:21 |
| Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform |
Globe Newswire |
02/27 |
04:00 |
| Li Auto Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 |
Globe Newswire |
02/27 |
04:00 |
| CUDIS Launches Sporty Series Ring with AI Coach and Integrated Access to Healthcare Providers |
Globe Newswire |
02/27 |
02:00 |
| FRO – Fourth Quarter and Full Year 2025 Results |
Globe Newswire |
02/27 |
01:28 |
